crohn's disease and semaglutide 5 Things Not to Say to Someone With Crohn’s GLP-1 Use in Crohn's Disease:

Tarbell JM, Cancel LM

Interestingly, longer exposure times suppress GLP-1 release (Chimerel et al., 2014), which may be important in gut-brain signaling regulation

The powder content dissolves easily and begins acting on the body quickly, offering better results and convenience

Tirzepatide-Specific Considerations Tirzepatide appears to have slightly higher rates of GI side effects compared to Semaglutide in head-to-head trials, though discontinuation rates remain relatively low

One added benefit to a GLP-1 in pill form is that it requires no refrigeration (as injectables do) and isnt dependent on the timing of meals or liquid intake, the research team said